The global market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) is increasing significantly. The market has huge scope due to growing demand for blood transfusion across the world. For the purpose of transfusion, donor blood compatibility with recipient patient is highly important. Thus, before transfusion of blood, in order to check compatibility, blood samples are cross-matched with each other. Transfusion of blood is usually safe, however, allo-immunization can create a complications in recipient. The allo-immunization can be dreadful in patients’ suffering from diseases like sickle cell anemia. The molecular blood group typing is used to determine presence of antigens in the red blood cells through testing. In general, A, B, and D (Rh) antigens are tested as part of standard procedure, followed by determination of other antigens if required. Reverse grouping confirms ABO blood group typing by detecting expected isoagglutinins. The varying use of blood typing and grouping test in research activities and transfusion procedures has upsurge the molecular blood typing, grouping and infectious disease nucleic acid testing market. Thus, rising demand, increased government interventions has increased the market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT). However, restraining factors like administrative and logistical challenges, slow turnaround, high cost, requirement of high end equipment and inadequate information systems for handling the results. Owing to these facts, the market observes rise in the demand for molecular typing tests. The adoption of molecular testing in blood transfusion procedures has mitigated the challenges faced to significant extent.
On the basis of nature of tests, blood typing and grouping tests are classified into ABO, Antibody Screening/Indirect Antiglobulin, Antibody Panels, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Rh (D, Du), Crossmatching (Immediate Spin, Full Crossmatch), etc. The cross-matching test has significant market share, followed by Antigen Typing in the molecular blood typing, grouping and infectious disease nucleic acid testing market.
Molecular diagnostics is gaining its popularity in transfusion procedures. The molecular diagnostics including NAT testing of infectious diseases has increased the safety of blood products and ensure blood group typing in critical situations such as prenatal non-invasive RhD typing and/or post-transfusion of blood products. Nucleic acid testing (NAT) in conjugation with serological procedures offers infectious disease screening standard which is generally used by blood banks globally. The evidence of positive impact of NAT blood screening on public health was observed globally. This led the rising potential for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) market. On the basis of infectious disease screening tests, the market is classified as Cytomegalovirus, AIDS (HIV NAT, HIV-1/2), Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), Parvovirus B19 NAT, HTLV-I/II, West Nile Virus NAT, Syphilis, etc.
Based on applications, the molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) market is classified into hospitals, diagnostic labs, research labs, blood banks, etc. the majority of share of market is occupied by blood banks.
Geographically, North America occupies the largest market share followed by other developed region like Europe. United States have been the major market across the world. High and advanced technology, research and development activities has boosted the North America market for molecular blood typing, grouping and infectious disease nucleic acid testing. Moreover, Asia Pacific has shown striking increase in its growth rate for the molecular blood typing, grouping and infectious disease nucleic acid testing market. Rising population, increase in disposable income are some key factors driving the Asia Pacific Market. Due to this factors, the Asian market is observing high number of new entrants compared to those in developed regions.
The Major players reported in the market include Abbot Laboratories, Becton Dickinson, Bio-Rad, Thermo Fisher Scientific Inc., Danaher Corporation, etc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.